Cynosure,
חטיבה של Hologic,
השיקה את StimSure®, טכנולוגיה
אלקטרומגנטית לא פולשנית לבנייה וחיזוק של שרירים בבטן, בישבן ובירכיים, באירופה
ובמזרח התיכון. התוספת החדשה לתיק מוצרי עיצוב הגוף של Cynosure מצטרפת ל-SculpSure® ו-TempSure® כדי
לאפשר ללקוחות להציע פתרון לכל הגוף.
Cynosure Extends Body Contouring Portfolio with Launch of StimSure® in Europe
State-of-the-art,
non-invasive system builds and tones muscle in the abdomen, buttocks and thighs
MARLBOROUGH,
Mass, 29 October, 2019, (BUSINESS
WIRE):
Cynosure,
a division of Hologic, has launched StimSure®, a non-invasive
electromagnetic technology to build and tone muscle in the abdomen, buttocks and
thighs, in Europe and the Middle East. This new addition to Cynosure’s body
portfolio joins SculpSure® and TempSure® to
enable customers to offer a full body solution.
StimSure
is a state-of-the-art, non-invasive electromagnetic muscle building and toning
treatment. CE marked for muscular atrophy, it can be used to strengthen and
tighten the abdominal, gluteal and thigh muscles by contracting/stimulating the
muscles, delivering up to 24,000 muscle contractions in just 20 to 30 minutes
for natural-looking results.
“We are
committed to offering our customers a range of innovative technologies that are
not only effective, but also deliver on quality and durability,” said Jan
Verstreken, Hologic’s Regional President, EMEA & Canada. “The addition of
StimSure to our portfolio of body contouring products, which includes
WarmSculpting™ by SculpSure for fat destruction and TempSure for skin
tightening, will enable our customers to offer their patients a full body
shaping package.”
The
StimSure applicators generate an electromagnetic field that stimulates the
motor neuron cells of the body’s muscles, causing the muscle to contract as it
would during movement or exercise. A prolonged contraction, made by a series of
individual twitch contractions back to back, creates a ‘maximal tetanic
contraction’ that results in more efficient growth of muscle fibers. StimSure
uses 1.0 Tesla per applicator, providing an electromagnetic field that can
engage the entire target muscle group.
With four
pre-set programs and the ability to create personalized programs on StimSure,
customers can tailor treatments for the individual. StimSure is suitable for a
wide range of people, but is not intended for weight loss, nor is it suitable
for obese patients. StimSure is simple to operate, with a secure fixing belt,
and can be used through light clothing. Either one or two applicators can be
used, and an applicator arm is available. For optimum results, six to eight
treatments (twice a week) are recommended.
StimSure
is only available in selected countries within the EMEA and Australasia
regions. It is not available in the USA.
About
Hologic, Inc.
Hologic,
Inc. is an innovative medical technology company primarily focused on improving
women’s health and well-being through early detection and treatment. For more
information on Hologic, visit www.hologic.com.
Hologic,
The Science of Sure and associated logos are registered trademarks of Hologic,
Inc. and/or its subsidiaries in the United States and/or other countries.
Cynosure and SculpSure are registered trademarks of Cynosure, LLC.
Forward-Looking
Statements
This news
release may contain forward-looking information that involves risks and
uncertainties, including statements about the use of Hologic products. There
can be no assurance these products will achieve the benefits described herein
or that such benefits will be replicated in any particular manner with respect
to an individual patient, as the actual effect of the use of the products can
only be determined on a case-by-case basis. In addition, there can be no
assurance that these products will be commercially successful or achieve any
expected level of sales. Hologic expressly disclaims any obligation or
undertaking to release publicly any updates or revisions to any such statements
presented herein to reflect any change in expectations or any change in events,
conditions or circumstances on which any such data or statements are based.
Source: Hologic, Inc.
